Should the best mismatched donor be chosen based on KIR typing? KIR role in transplantation and implications

Written by Vera Siffnerová (FAS, Omixon) A choice of the most suitable donor for each transplant patient has always been the main focus and challenge for the whole team that is involved in the selection process. There is a high number of criteria that are evaluated, different approaches and...

 

Read more

Interview with Prof. Milena Ivanova MD, Molecular Biologist from the University Hospital Aleksandrovska

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. In this interview, Prof. Milena Ivanova MD, Molecular Biologist from the University Hospital Aleksandrovska talks about their experiences and thoughts on HLA laboratory activities....

 

Read more

HLA EXPLORE™ can help you in your COVID research and Omixon offers 50% off the annual licence fee for Research Institutions until the end of 2020

HLA Explore NGS software can analyze any experiment type – targeted exons, targeted whole genes, whole MHC, whole transcriptome, whole exome or whole genome – of your patient’s NGS samples.   While recovering from the COVID crises Omixon offers 50% off the annual licence fee for Research Institutions until the...

 

Read more

ASHI, October 19-23, 2020

We would like to inform you about ASHI 2020 Conference which will be held virtually. Omixon is thrilled to be sponsoring and participating at the 46th ASHI Annual Meeting with a Silver Sponsorship in 2020. We are proud supporters of a number of initiatives, organisations and events throughout our...

 

Read more